53484-76-7 Usage
General Description
4-Phenyl-4-piperidine carboxylic acid HCl is a chemical compound that consists of a piperidine ring with a phenyl group and a carboxylic acid moiety attached to it. The compound is usually found in the form of a hydrochloride salt, denoted by the HCl in its name. It is commonly used as an intermediate in the synthesis of pharmaceuticals and other organic compounds. The presence of the piperidine ring makes this compound a potential candidate for drug design and development due to its pharmacological properties. Additionally, the presence of the carboxylic acid group makes it useful for chemical reactions and as a building block in organic synthesis.
Check Digit Verification of cas no
The CAS Registry Mumber 53484-76-7 includes 8 digits separated into 3 groups by hyphens. The first part of the number,starting from the left, has 5 digits, 5,3,4,8 and 4 respectively; the second part has 2 digits, 7 and 6 respectively.
Calculate Digit Verification of CAS Registry Number 53484-76:
(7*5)+(6*3)+(5*4)+(4*8)+(3*4)+(2*7)+(1*6)=137
137 % 10 = 7
So 53484-76-7 is a valid CAS Registry Number.
53484-76-7Relevant articles and documents
NOVEL HETEROCYCLIC SUBSTITUTED PYRROLIDINE AMIDE DERIVATIVES
-
, (2008/06/13)
The present invention relates to novel heterocyclic substituted pyrrolidine amide derivatives of formula (1), and stereoisomers and pharmaceutically acceptable salts thereof and their use as tachykinin receptor antagonists. Such antagonists are useful in the treatment of tachykinin-mediated diseases and conditions disclosed herein including: asthma, cough, and bronchitis.
SUBSTITUTED PYRROLIDIN-3-YL-ALKYL-PIPERIDINES
-
, (2008/06/13)
The present invention relates to substituted pyrrolidinyl-3-yl-alkyl-piperidines, their stereoisomers, and pharmaceutically acceptable salts thereof and processes for preparation of the same. The compounds of the present invention are useful in their pharmacological activities such as tachykinin antagonism, especially substance P and neurokinin A antagonism, and the like. Compounds having the property of tachykinin antagonism are indicated for conditions associated with neurogenic inflammation and other diseases described herein.